Antibody Sequences

EVQLV Submits First Panel of Optimized Antibody Sequences

EVQLV Submits First Panel of Optimized Antibody Sequences

EVQLV, has submitted their first panel of candidate therapeutic antibody sequences, comprised of DNA sequences encoding for potentially therapeutic antibodies against the new coronavirus, SARS-CoV-2. These DNA sequences were generated using computational antibody design, a method which combines mathematics, statistics, and computer science to identify high-affinity antibodies.

read more

Pin It on Pinterest